Status:
COMPLETED
Effects of Dexmedetomidine on Modulation of Perioperative Blood Glucose and Related Hormones
Lead Sponsor:
Zhuan Zhang
Conditions:
Dexmedetomidine
Blood Glucose
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The investigators aimed to explore effects of dexmedetomidine on modulation of perioperative blood glucose and relevant hormone during the general anesthesia with surgery time ≥ 4 hours, and the effec...
Eligibility Criteria
Inclusion
- \- patients undergoing operations over 4 h under general anesthesia,ASA physical status I or II, irrespective of showing gender bias, aged between 50-75 years old, and having a body mass index (BMI) between 18.5-28 kg/m2.
Exclusion
- the patients with bradycardia, hypoglycemia, heart disease, adrenal tumor,diabetes or showed ≥7.0 mmol/L, or HbA1c level ≥6.5%.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03788538
Start Date
November 1 2017
End Date
June 1 2020
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Affiliated Hospital of Yangzhou University, Yangzhou University
Yangzhou, Jiangsu, China, 225012